Experimental Drug Cancels Effect from Key Intellectual Disability Gene

News   Apr 28, 2016

 
Experimental Drug Cancels Effect from Key Intellectual Disability Gene
 
 
 

RELATED ARTICLES

Diagnosis and Treatment of Heart and Circulatory Diseases a Top Priority for the UK

News

NHS commits to a new focus around heart and circulatory diseases in 10 year plan

READ MORE

Modified Form of Botox Could Replace Opioids as Treatment for Chronic Pain

News

A modified form of botulinum toxin gives long-lasting pain relief in mice without adverse effects and, in time, could replace opioid drugs as a safe and effective way of treating chronic pain, according to new research.

READ MORE

DNA ‘Shield’ Discovered with Crucial Roles in Normal Cell Division, the Immune System & Cancer

News

Scientists have made a major discovery about how cells repair broken strands of DNA that could have huge implications for the treatment of cancer.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy